Evidence map›Paper›PMID 42716684›Full record

ArticleBMJ open2026

Health-related quality of life in patients with cancer in Lubumbashi/Democratic Republic of the Congo: a semi-structured qualitative and quantitative prospective cross-sectional study.

Micha Johannes Pilz, Johannes Maria Giesinger, Scholastique Mutoke, Gladys Kavira, André Ngombe Kaseba, Nelly Epule, Peter Kitenge, Marie-France Basema, Fanny Mafuta Shabani, Juan Ignacio Arraras and 3 more

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Micha Johannes PilzHealth Outcomes Research Unit, University Hospital of Psychiatry II, Medical University Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0003-4092-8797
Johannes Maria GiesingerHealth Outcomes Research Unit, University Hospital of Psychiatry II, Medical University Innsbruck, Innsbruck, Austria.
Scholastique MutokeÉcole de Santé Publique, Université de Lubumbashi, Lubumbashi, Congo (the Democratic Republic of the).
Gladys KaviraÉcole de Santé Publique, Université de Lubumbashi, Lubumbashi, Congo (the Democratic Republic of the).
André Ngombe KasebaÉcole de Santé Publique, Université de Lubumbashi, Lubumbashi, Congo (the Democratic Republic of the).
Nelly EpuleÉcole de Santé Publique, Université de Lubumbashi, Lubumbashi, Congo (the Democratic Republic of the).
Peter KitengeÉcole de Santé Publique, Université de Lubumbashi, Lubumbashi, Congo (the Democratic Republic of the).
Marie-France BasemaÉcole de Santé Publique, Université de Lubumbashi, Lubumbashi, Congo (the Democratic Republic of the).
Fanny Mafuta ShabaniÉcole de Santé Publique, Université de Lubumbashi, Lubumbashi, Congo (the Democratic Republic of the).
Juan Ignacio ArrarasMedical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain.
Sifa B MitterlehnerDepartment for Anaesthesiology, New Somerset Hospital, Cape Town, South Africa.
Lára R HallssonDepartment of Public Health, Health Services Research, and Health Technology Assessment, UMIT TIROL-University for Health Sciences and Technology, Hall i. Tyrol, Austria.
Albert Mwembo Tambwe-A-NkoyÉcole de Santé Publique, Université de Lubumbashi, Lubumbashi, Congo (the Democratic Republic of the) mwembotambwea@unilu.ac.cd.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHealth-related quality of life (HRQoL) assessments are a cornerstone of outcome evaluations for patients with cancer. The aim of this project was to assess patients with cancer in Lubumbashi/Democratic Republic of the Congo and: (1) evaluate what constitutes a clinically important health problem, (2) evaluate HRQoL and (3) compare HRQoL to controls.

designCross-sectional, prospective study.

settingPatient recruitment took place in 12 hospitals in Lubumbashi.

participantsInclusion criteria were a secured diagnosis of cancer, aged 18 years and above, no serious cognitive impairments. PRIMARY AND SECONDARY OUTCOME MEASURES: (1) Semi-structured interviews with patients and healthcare professionals were conducted to investigate aspects of clinical importance. (2) The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) was employed to quantitatively assess HRQoL; (3) an exploratory comparison of HRQoL data to Spanish controls, multinational reference data and the European general population data is performed.

results(1) 20 patients (x̄-age=55.0 years; 70.0% female) and 10 healthcare professionals were interviewed. Social isolation, need for help/care and worries were frequently mentioned aspects making a health problem clinically important. (2) 103 patients (x̄-age=54.0 years; 67.0% female) with various cancer types were assessed. The prevalence of clinically important problems ranged from 26.2 % for fatigue to 94.1% for financial problems. (3) Compared to matched Spanish controls (n=207), symptom burden was more pervasive (OR 1.18 for insomnia to 28.0 for financial problems) than functional health limitations (max. OR 2.12 for role function). While adjusting HRQoL scores for age, sex, comorbidities and treatment intention decreased effect sizes of score difference across countries for 14 out of 16 scales, statistically significant differences across countries (p<0.05) remained for ten scales even after adjusting for covariates.

conclusionClinical characteristics, aspects of clinical importance and HRQoL profiles of patients with cancer in Lubumbashi were reported. Aspects of clinical importance were identified, whereas a high symptom burden was reported by patients with cancer in Lubumbashi. Enhancing symptom management in Lubumbashi may alleviate symptom burden of patients with cancer.

Indexed as

Health StatusNeoplasmsQuality of LifeAdultAgedCross-Sectional StudiesDemocratic Republic of the CongoFemaleHumansMaleMiddle AgedProspective StudiesQualitative ResearchSurveys and QuestionnairesAfrica South of the SaharaCancerPatient Reported Outcome Measures

Identifiers

PMID42716684
PMCPMC13560954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.